Children of God for Life welcomes the approval of Japan’s long‑awaited combination MMR (measles, mumps, rubella) vaccine. JVC‑001 uses the measles AIK‑C, mumps RIT4385, and rubella Takahashi strains, all produced using non‑aborted fetal cell lines derived from chick embryo and rabbit cells. This makes it the only ethically untainted combination MMR vaccine available anywhere in the world.
Families outside of Japan continue to remain unjustly denied access. Many are forced to travel to Japan at tremendous personal cost simply to obtain an ethical option—fourteen families did so last year alone, and inquiries continue to rise. Supplies have dwindled, and the short term availability of the MR vaccine remains uncertain. Until ethical untainted vaccines are accessible worldwide, families will continue to face an absolutely unnecessary and deeply unjust moral burden.
The updatad combination vaccine, developed by Daiichi Sankyo Co., has been reviewed and cleared for final approval by the health minister.
Japan has not offered a routine combined MMR vaccine for more than 30 years. The vaccine was removed from the national immunization program in 1993 after some children experienced serious side effects, including cases of aseptic meningitis. It was determined that the previous strain of Mumps used was not in good combination with the other components.
Health experts stated that the newly approved vaccine was carefully evaluated with those past experiences in mind. In clinical trials involving more than 900 healthy one‑year‑old children, researchers found no cases of aseptic meningitis and no serious safety problems that caused children to stop participating in the studies.
The vaccine, known as JVC‑001, combines protection against measles, mumps, and rubella in a single shot. Two large phase 3 studies tested how well children’s immune systems responded and monitored side effects.
According to the researchers, the vaccine produced very strong immune responses against measles and rubella, with more than 99 percent of children developing protective antibodies. Protection against mumps was slightly lower than that of existing mumps vaccines, but researchers said the results still showed consistent effectiveness and no new safety concerns.
Health officials say the new MMR vaccine is expected to have a lower risk of serious side effects than earlier versions and could help protect children against three contagious diseases with one injection.
See the following links for further information
https://sp.m.jiji.com/english/show/46122
https://www.sciencedirect.com/science/article/pii/S0264410X2401380X?via%3Dihub